Literature DB >> 31619468

Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.

Byung Woo Jhun1,2, Seong Mi Moon3,2, Kyeongman Jeon4, O Jung Kwon4, Heejin Yoo5, Keumhee C Carriere5,6, Hee Jae Huh7, Nam Yong Lee7, Sung Jae Shin8,9,10, Charles L Daley11,12, Won-Jung Koh4.   

Abstract

Limited data are available regarding the prognostic factors for patients with nontuberculous mycobacterial pulmonary disease (NTM-PD). We investigated the prognostic factors associated with long-term mortality in NTM-PD patients after adjusting for individual confounders, including aetiological organism and radiological form.A total of 1445 patients with treatment-naïve NTM-PD who were newly diagnosed between July 1997 and December 2013 were included. The aetiological organisms were as follows: Mycobacterium avium (n=655), M. intracellulare (n=487), M. abscessus (n=129) and M. massiliense (n=174). The factors associated with mortality in NTM-PD patients were analysed using a multivariable Cox model after adjusting for demographic, radiological and aetiological data.The overall 5-, 10- and 15-year cumulative mortality rates for the NTM-PD patients were 12.4%, 24.0% and 36.4%, respectively. On multivariable analysis, the following factors were significantly associated with mortality in NTM-PD patients: old age, male sex, low body mass index, chronic pulmonary aspergillosis, pulmonary or extrapulmonary malignancy, chronic heart or liver disease and erythrocyte sedimentation rate. The aetiological organism was also significantly associated with mortality: M. intracellulare had an adjusted hazard ratio (aHR) of 1.40, 95% CI 1.03-1.91; M. abscessus had an aHR of 2.19, 95% CI 1.36-3.51; and M. massiliense had an aHR of 0.99, 95% CI 0.61-1.64, compared to M. avium Mortality was also significantly associated with the radiological form of NTM-PD for the cavitary nodular bronchiectatic form (aHR 1.70, 95% CI 1.12-2.59) and the fibrocavitary form (aHR 2.12, 95% CI 1.57-3.08), compared to the non-cavitary nodular bronchiectatic form.Long-term mortality in patients with NTM-PD was significantly associated with the aetiological NTM organism, cavitary disease and certain demographic characteristics.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 31619468     DOI: 10.1183/13993003.00798-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Mycobacterium abscessus pathogenesis identified by phenogenomic analyses.

Authors:  Lucas Boeck; Sophie Burbaud; Marcin Skwark; Will H Pearson; Jasper Sangen; Andreas W Wuest; Eleanor K P Marshall; Aaron Weimann; Isobel Everall; Josephine M Bryant; Sony Malhotra; Bridget P Bannerman; Katrin Kierdorf; Tom L Blundell; Marc S Dionne; Julian Parkhill; R Andres Floto
Journal:  Nat Microbiol       Date:  2022-08-25       Impact factor: 30.964

2.  Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.

Authors:  Ganghee Chae; Yea Eun Park; Yong Pil Chong; Hyun Joo Lee; Tae Sun Shim; Kyung-Wook Jo
Journal:  Antimicrob Agents Chemother       Date:  2022-08-11       Impact factor: 5.938

3.  Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.

Authors:  Hsin-Hua Chen; Ching-Heng Lin; Wen-Cheng Chao
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

4.  Novel Screening System of Virulent Strains for the Establishment of a Mycobacterium avium Complex Lung Disease Mouse Model Using Whole-Genome Sequencing.

Authors:  Koji Furuuchi; Shintaro Seto; Hajime Nakamura; Haruka Hikichi; Akiko Miyabayashi; Keiko Wakabayashi; Kazue Mizuno; Teruaki Oka; Kozo Morimoto; Minako Hijikata; Naoto Keicho
Journal:  Microbiol Spectr       Date:  2022-05-17

5.  Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease.

Authors:  Seong Mi Moon; Su-Young Kim; Dae Hun Kim; Hee Jae Huh; Nam Yong Lee; Byung Woo Jhun
Journal:  Antimicrob Agents Chemother       Date:  2022-03-10       Impact factor: 5.938

6.  Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio According to the Radiologic Severity of Mycobacterium avium Complex Pulmonary Disease.

Authors:  Mi-Ae Kim; Yea Eun Park; Yong Pil Chong; Tae Sun Shim; Kyung-Wook Jo
Journal:  J Korean Med Sci       Date:  2022-10-17       Impact factor: 5.354

7.  Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.

Authors:  Shunsuke Mori; Yukinori Koga; Kazuyoshi Nakamura; Sayuri Hirooka; Takako Matsuoka; Hideshi Uramoto; Osamu Sakamoto; Yukitaka Ueki
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

8.  Safety and Efficacy of Nontuberculous Mycobacteria Treatment among Elderly Patients.

Authors:  Yoshitaka Uchida; Jiro Terada; Tetsuya Homma; Hatsuko Mikuni; Kuniaki Hirai; Haruhisa Saito; Ryoichi Honda; Hironori Sagara
Journal:  Medicina (Kaunas)       Date:  2020-10-02       Impact factor: 2.430

9.  Characterization of integrated prophages within diverse species of clinical nontuberculous mycobacteria.

Authors:  Cody Glickman; Sara M Kammlade; Nabeeh A Hasan; L Elaine Epperson; Rebecca M Davidson; Michael Strong
Journal:  Virol J       Date:  2020-08-17       Impact factor: 4.099

10.  Efficacy estimation of a combination of triple antimicrobial agents against clinical isolates of Mycobacterium abscessus subsp. abscessus in vitro.

Authors:  Takahiro Asami; Akio Aono; Kinuyo Chikamatsu; Yuriko Igarashi; Yuta Morishige; Yoshiro Murase; Hiroyuki Yamada; Akiko Takaki; Satoshi Mitarai
Journal:  JAC Antimicrob Resist       Date:  2021-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.